Pacific Biosciences
PACB
#6687
Rank
HK$5.33 B
Marketcap
HK$17.66
Share price
-4.64%
Change (1 day)
47.09%
Change (1 year)

EPS for Pacific Biosciences (PACB)

EPS in 2025 (TTM): -HK$13.24

According to Pacific Biosciences 's latest financial reports the company's current EPS (TTM) is -HK$13.28. In 2024 the company made an earnings per share (EPS) of -HK$8.91 an increase over its 2023 EPS that were of -HK$9.45.

EPS history for Pacific Biosciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$13.2448.61%
2024-HK$8.91-5.79%
2023-HK$9.45-13.57%
2022-HK$10.9457.3%
2021-HK$6.95-841.67%
2020HK$0.94-121.79%
2019-HK$4.30-28.49%
2018-HK$6.02-13.48%
2017-HK$6.95
2015-HK$3.36-54.21%
2014-HK$7.34-24.69%
2013-HK$9.74-26.65%
2012-HK$13.28

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
HK$135.47-1,120.00%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
HK$59.06-544.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
HK$34.92-362.94%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
HK$60.16-552.93%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoString Technologies
NSTG
-HK$27.58 107.65%๐Ÿ‡บ๐Ÿ‡ธ USA